Medical News

RSS

American Pain Society urges Congress to resist NIH budget cuts

The American Pain Society, www.americanpainsociety.org, today condemned the Trump Administration's proposed 19 percent cut in funding for the National Institutes of Health and warned that such a draconian budget reduction would devastate biomedical research in the United States unless Congress acted to prevent it.

31 Mar 2017

Occupational exposure to biocides associated with higher risk of thyroid cancer

Workers exposed to chemicals like deodorizers, sanitizers, disinfectants and sterilizers on the job may be more likely than other people to develop thyroid cancer, a recent study suggests.

31 Mar 2017

Study provides new understanding of molecular mechanisms of HPV-induced tumors

The incidence of human papillomavirus (HPV)-associated (HPV+) head and neck squamous cell carcinoma (HNSCC) of the oropharynx has dramatically increased over the last decade and is now more frequently diagnosed than uterine cervical cancer in the United States.

31 Mar 2017

USAHS experts to present key occupational therapy research at AOTA Annual Conference

University of St. Augustine Health Sciences, a leading graduate institution that emphasizes health science education through innovative classroom education, is proud to announce that several faculty members will be presenting key research at the American Occupational Therapy Association Annual Conference & Centennial Celebration in Philadelphia, March 30 - April 2.

31 Mar 2017

Partnership for Quality Home Healthcare commends CMS for stopping pre-claim review demonstration

The Partnership for Quality Home Healthcare — a coalition of home health providers dedicated to improving the integrity, quality, and efficiency of home healthcare for our nation's seniors — today commended the Centers for Medicare & Medicaid Services for stopping the planned implementation of a Pre-Claim Review Demonstration in Florida, which would have applied new, mandatory regulatory requirements on all home health agenciesoperating across the state on April 1.

31 Mar 2017

Investigational compound for treating indolent lymphomas shows positive results in phase II clinical study

Bayer today announced positive data on its investigational compound copanlisib, an intravenous pan-Class I phosphatidylinositol-3-kinase (PI3K) inhibitor with predominant inhibitory activity against PI3K-α and PI3K-δ isoforms.

31 Mar 2017

Northwestern Memorial first in Illinois to integrate combined MR-PET scanner into health care system

Northwestern Memorial Hospital is now home to the Chicago area's first combined magnetic resonance and positron emission tomography scanner, a machine that shortens the total time a patient spends in imaging tests while providing exceptional image quality at lower doses of radiation.

31 Mar 2017

Firstcare Health Plans wins TDC award for third consecutive year

In late 2016, FirstCare Health Plans received word from the Texas Diabetes Council (TDC) and the Texas Department of State Health Services (DSHS) that it was being honored for performing above the Texas average for Healthcare Effectiveness Data and Information Set (HEDIS) performance measures for blood glucose control (A1c), blood pressure and cholesterol treatments related to diabetes care in 2015 for our Abilene and Waco service areas.

31 Mar 2017

RI International and BHL to introduce CrisisTech360 app at NATCON17

RI International CEO and President David Covington announced the launch of the CrisisTech360 app today, providing 24/7/365 real-time visibility of crisis bed availability and program data.

31 Mar 2017

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

QIAGEN N.V. today announced it is commercializing the Research use only AdnaTest Prostate Cancer Panel AR-V7 to detect the androgen receptor splice variant 7 (AR-V7) from liquid biopsies to investigate resistance to potential drugs for advanced prostate cancer.

From QIAGEN Manchester Limited 31 Mar 2017

NIHR Innovation Observatory to aid future advances in healthcare

Future advances in healthcare will be aided by a new £10 million facility - the National Institute for Health Research Innovation Observatory.

31 Mar 2017

New smartwatch app helps men to boost sexual performance

Simply180, a full service marketing and advertising agency announced today the beta launch of "Fitdix", a new app it developed that uses smartwatch and artificial intelligence technology to help men end their reliance on pharmaceuticals to boost sexual performance and reduce premature ejaculation.

31 Mar 2017

New report highlights need for rapid research progress and improved outcomes in pancreatic cancer

The new report highlighting trends in cancer released today by the American Cancer Society, the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI) points to the urgent need for more research and funding in pancreatic cancer.

31 Mar 2017

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Novocure announced today results from the second cohort of its phase 2 pilot PANOVA trial studying Tumor Treating Fields (TTFields) in combination with nab-paclitaxel and gemcitabine for the treatment of advanced pancreatic cancer.

31 Mar 2017

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Novocure announced today results from its phase 2 pilot INNOVATE trial studying Tumor Treating Fields (TTFields) in combination with weekly paclitaxel for the treatment of recurrent ovarian cancer.

31 Mar 2017

ISS crew members grow crystals for drug development

Crew members aboard the International Space Station will begin conducting research this week to improve the way we grow crystals on Earth. The information gained from the experiments could speed up the process for drug development, benefiting humans around the world.

31 Mar 2017

Case Western Reserve and Q2 Pharma partner to develop antivirulence agents that disarm superbugs

Case Western Reserve University and Q2 Pharma Ltd., an Israeli biopharmaceutical company, have signed a two-year option to license small molecule, antivirulence technology to potentially treat bacterial infections such as methicillin-resistant staphylococcus aureus (MRSA), the first known scientific effort of its kind.

31 Mar 2017

Medical News

American Pain Society urges Congress to resist NIH budget cuts

Occupational exposure to biocides associated with higher risk of thyroid cancer

Study provides new understanding of molecular mechanisms of HPV-induced tumors

USAHS experts to present key occupational therapy research at AOTA Annual Conference

Partnership for Quality Home Healthcare commends CMS for stopping pre-claim review demonstration

Investigational compound for treating indolent lymphomas shows positive results in phase II clinical study

Northwestern Memorial first in Illinois to integrate combined MR-PET scanner into health care system

Firstcare Health Plans wins TDC award for third consecutive year

RI International and BHL to introduce CrisisTech360 app at NATCON17

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

NIHR Innovation Observatory to aid future advances in healthcare

New smartwatch app helps men to boost sexual performance

New report highlights need for rapid research progress and improved outcomes in pancreatic cancer

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

ISS crew members grow crystals for drug development

Case Western Reserve and Q2 Pharma partner to develop antivirulence agents that disarm superbugs

New research to explore how socio-economic factors, other health concerns affect cancer treatment

Experts to discuss new paradigms in healthcare monitoring and management

Phase 2 clinical study of investigational Zika vaccine begins in the U.S., Central and South America

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News